GoldBamboo.com - Knowledge is strong medicine
  

Effect of Family-Based Prevention on Children of Depressed Parents - Article


  Not Signed In - Sign In / Register






Youth Risk Behavior Surveillance System

YRBSS


Clinical Trial: Effect of Family-Based Prevention on Children of Depressed Parents

This study is not yet open for patient recruitment.
Verified by National Institute of Mental Health (NIMH) September 2005

Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00183365

Purpose

This study will test the Protecting Families Program, a 10-week prevention program for depressed parents and their pre-teenage children, by comparing the effectiveness of the program versus parent training alone.
Condition Intervention Phase
Depression
 Behavior: Penn Optimism Program (POP)
 Behavior: Parent Skills Training
 Behavior: Community Meal
 Behavior: Emotional Coaching
Phase I

MedlinePlus related topics:  Depression

Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Official Title: Children of Depressed Parents: Family-Based Prevention

Further Study Details: 
Primary Outcomes: Child psychiatric symptomology immediately post-intervention and 6 months post-intervention
Secondary Outcomes: Parenting skills, family functioning, and parent social support immediately post-intervention and 6 months post-intervention
Expected Total Enrollment:  42

Study start: October 2005

Children of depressed parents are at risk for developing social-emotional problems. Despite the fact that economic hardship is a strong risk factor for both maternal depression and poor child development, little research has been conducted to develop prevention programs for low-income urban families. This randomized, open-label study will address the research gap by developing and pilot-testing the Protecting Families Program (PFP), a family-based, multi-component prevention program. The PFP will offer its services to low-income, urban, depressed parents and their children between the ages of 9 and 12.

Prior to the interventional portion of the study, several small focus groups composed of mental-health care providers and depressed parents will meet. The purpose of these focus groups will be to gather information that will help maximize the effectiveness of the remainder of the study. The interventional phase will compare PFP combined with individual parent training versus parent training alone. Participants will be randomly assigned to one of these two intervention groups. The study will last a total of 10 weeks. Both groups will meet once each week. PFP will include a community meal at the beginning of each session, a parent skills training group, and a concurrent cognitive behavioral therapy (CBT) group for the focal child. Participants’ symptoms, diagnosis, functional status, family functioning, cognitive factors, and parenting practices will be assessed at the study start date, immediately post-intervention, and 6 months post-intervention.

Eligibility

Ages Eligible for Study:  9 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • Parent is currently in treatment
  • Parent’s primary DSM-IV diagnosis is major depressive disorder, dysthymia, or depression not otherwise specified
  • Parent’s child (age 9-14) lives with him/her at least part time

Exclusion criteria:

  • Parent has a history or current diagnosis of any psychotic disorder or organic brain syndrome
  • Parent has history of bipolar or schizoaffective disorder
  • Parent’s IQ is below 70
  • Parent has any serious medical or neurological disorder or condition that may prevent weekly participation
  • Parent has chronic pain that may prevent weekly participation
  • Parent or child is currently suicidal to the extent that it will interfere with outpatient treatment
  • Parent has a current substance dependence
  • Child is currently seeking psychological treatment
  • Child is mentally retarded (determined by school and clinic records)
  • Child has a clinically severe psychiatric diagnosis

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00183365

Natashia M. Robbins, M.S.      267-426-5104    robbinsn@email.chop.edu

Pennsylvania
      Center for Family Intervention Science; The Children''''s Hospital of Philadelphia, Philadelphia,  Pennsylvania,  19104,  United States
Natashia M. Robbins, M.S.  267-426-5104    robbinsn@email.chop.edu 

Study chairs or principal investigators

Guy Diamond, Ph.D.,  Principal Investigator,  University of Pennsylvania / CHOP   
Rhonda Boyd, Ph.D.,  Principal Investigator,  University of Pennsylvania / CHOP   

More Information

Study ID Numbers:  MH71868-01
Last Updated:  September 15, 2005
Record first received:  September 12, 2005
ClinicalTrials.gov Identifier:  NCT00183365
Health Authority: United States: Institutional Review Board; United States: Federal Government
ClinicalTrials.gov processed this record on 2005-09-20


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Youth Risk Behavior Surveillance System.

October 13, 2008



Page Updated: November 22, 2004
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Massachusetts Law | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.